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Abstract
Background: Clinical suspects of pulmonary tuberculosis in which the sputum smears are negative for acid fast bacilli
represent a diagnostic challenge in resource constrained settings. Our objective was to validate an existing clinical-
radiographic score that assessed the probability of smear-negative pulmonary tuberculosis (SNPT) in high incidence settings
in Peru.
Methodology/Principal Findings: We included in two referral hospitals in Lima patients with clinical suspicion of pulmonary
tuberculosis and two or more negative sputum smears. Using a published but not externally validated score, patients were
classified as having low, intermediate or high probability of pulmonary tuberculosis. The reference standard for the
diagnosis of tuberculosis was a positive sputum culture in at least one of 2 liquid (MGIT or Middlebrook 7H9) and 1 solid
(Ogawa) media. Prevalence of tuberculosis was calculated in each of the three probability groups. 684 patients were
included. 184 (27.8%) had a diagnosis of pulmonary tuberculosis. The score did not perform well in patients with a previous
history of pulmonary tuberculosis. In patients without, the prevalence of tuberculosis was 5.1%, 31.7% and 72% in the low,
intermediate and high probability group respectively. The area under de ROC curve was 0.76 (95% CI 0.72–0.80) and scores
$6 had a positive LR of 10.9.
Conclusions/Significance: In smear negative suspects without previous history of tuberculosis, the clinical-radiographic
score can be used as a tool to assess the probability of pulmonary tuberculosis and to guide the decision to initiate or defer
treatment or to requesting additional tests.
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Introduction
In most low income countries, the diagnosis of pulmonary
tuberculosis continues to rely on the search for Acid-Fast Bacilli
(AFB) in sputum smears, which has a sensitivity between 50 and
80% [1–3]. This sensitivity varies according to factors such as the
number of smears examined, the compliance with laboratory
procedure guidelines, the training of personnel and patients
characteristics, including their HIV status [4]. Clinical suspects of
pulmonary tuberculosis (PTB) with negative sputum smears
constitute a diagnostic challenge, as many of them would result
positive if assessed with culture. Furthermore, smear negative
pulmonary tuberculosis (SNPT) represents an important public
health problem in many countries, with an estimated proportion of
between 30–60% of all tuberculosis cases, according to the setting
[1,3,5–7], and a mortality up to 25% [8] in populations with high
prevalence of HIV infection.
Access to culture is limited in many high tuberculosis incidence
environments. Furthermore, classical culture in solid media has
the important drawback of the time required before obtaining
results, which takes up to 6 weeks. Liquid media can significantly
shorten the diagnostic delay, but they are unaffordable for
laboratories in resource constrained settings. New molecular
techniques are also expensive, possibly only marginally helpful
for smear negative cases and their utility at a programmatic level is
still controversial [9].
The utility of exhaustive clinical evaluation of SNPT suspects
has not often been investigated in depth and in day to day practice
signs and symptoms are only being used according to the criteria
of the treating physician. Moreover, the clinical definitions in
existing guidelines are rather vague [10–12] and do not allow to
classify patients according to their probability of having tubercu-
losis. Some diagnostic algorithms and clinical decision rules for
assessing the probability of PTB among smear-negative suspects
have been proposed, but they have generally not been validated in
external populations [13–16]. We have previously developed in
Lima, Peru, a Clinical prediction rule in the form of a ‘‘score’’ for
assigning the probability of having SNPT in patients with clinical
suspicion of PTB and negative sputum smears [17]. Based on our
results, we recommended its use to classify patients as having low,
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intermediate or high probability of SNPT, in order to guide the
decision for intensified diagnostic workup. The purpose of the
present study was to prospectively assess the validity of this score in
an independent patient sample.
Methods
Objective
To validate a clinical-radiographic score that assess the
probability of pulmonary tuberculosis in suspect patients with
negative sputum smears in high incidence settings with limited
resources.
Participants
This study was conducted in Cayetano Heredia and Hipo´lito
Unanue Hospitals, two university-affiliated hospitals with a
catchment population of about two million people in Lima, Peru.
The area has a high incidence of tuberculosis (151/100000
population [18]) and a concentrated HIV/AIDS epidemic
(prevalence of less than 1 percent in general population [19]).All
consecutive adult patients, whether referred, self referred or
directly consulting that presented between September 2005 and
March 2008 in the departments of internal and pulmonary
medicine of the 2 hospitals with suspicion of PTB were evaluated
for eligibility.
Clinical suspicion of PTB was defined as the presence of cough
for at least 2 weeks and any of the following: fever, weight loss or
dyspnoea. PTB suspects were included after at least two negative
Acid Fast Bacilli (AFB) smears in conventional sputum specimens
either at a first line health facility or at the hospital level. Patients
diagnosed at that point with obvious other respiratory conditions
(e.g. asthmatic crises or COPD exacerbation) were excluded.
Description of Clinical and Laboratory procedures
At intake we collected information on the sociodemographic
and clinical characteristics of all participants in face to face
interviews.
We performed a chest X ray on each participant that was read
by the general practitioner (GP) in charge of the recruitment of
patients in each of the participating hospitals. They assessed
specifically the presence or absence of apical and/or miliary
infiltrates. The readings were blindly revised by a TB specialist in
the same hospital, and disagreement was resolved by an
experienced radiologist.
An additional sputum sample was taken for a concentrated
sputum smear (prepared after decontamination using 4% NaOH
and subsequent centrifugation) and cultures in Ogawa, Middleb-
rook 7H9 and Mycobacterial Growth Indicator tube (MGIT).
Laboratory personnel was blinded to the clinical history of the
patient. Voluntary HIV testing was performed after counselling.
Diagnostic work up for alternative diagnosis, if necessary, fell
under the responsibility of the treating physician and documenting
this process and its outcome was not a study objective.
Clinical score
The previously developed score was derived using logistic
regression, assigning points to each of the predictive findings
included in the model according to the strength and direction of
the association with smear negative TB [17], and optimal cut-off
points were identified with ROC analysis. It includes, in brief, four
clinical variables: age more than 45 years (-1 point), haemoptysis (2
points), weight loss (1 point) and expectoration (-1 point), and two
radiographic variables: apical infiltrate (3 points) and miliary
infiltrate (4 points). The total scores range from 22 to 10 points. A
patient is classified as having low (negative scores), intermediate (0
to 4 points) or high probability of tuberculosis (more than 4 points).
The personnel classifying the patients’ probabilities were blinded
to the laboratory results and vice versa.
Ethics
The study was conducted inside an ongoing research project
aiming at the development of a comprehensive clinical approach
towards the diagnosis of smear negative tuberculosis in Peru. It
was approved by the ethics committee of Universidad Peruana
Cayetano Heredia. Written informed consent was obtained from
all patients.
Statistical methods
SNPT was defined as a positive result in the concentrated smear
or growing of M. tuberculosis in any culture medium. The
association with each all individual predictors was initially assessed
by calculating bivariate Odds ratios. To evaluate the association
with the variables included in the score above, we performed
multiple logistic regression analysis including all the variables with
p values less than 0.2 in the bivariate analysis in addition to the
variables present in the score. The later were preserved in the final
model independently of the significance attained, while other
variables were dropped by backward elimination. The goodness of
fit of the model was assessed by means of Hosmer and Lemeshow
test.
We calculated for all included patients the total score and
classified them according to the corresponding degree of
probability of having SNPT (low, intermediate or high). The
prevalence of tuberculosis in each of these three groups was
established and the likelihood ratios corresponding to the score
cut-off points were calculated as well as the corresponding 95%
confidence intervals. We further stratified this analysis by previous
history of tuberculosis, since lung scarring can cause permanent
apical infiltrates as well as chronic cough, even in the absence of
active tuberculosis. Additionally, ROC curve analysis [20] was
performed. All analyses were done in STATA version 8.2 [21].
Results
A total of 780 smear negative pulmonary tuberculosis suspects
were recruited. 66 were excluded due to obvious other pathology
and 30 due to inability to produce sputum. Out of the 684 patients
included, 21 had incomplete information (7 had lost or
contaminated cultures and 14 incomplete clinical information),
and 663 were analyzed. Due to stock shortage between September
2005 to January 2006 and between July and September 2006,
MGIT could not be performed for 130 of them. The results can
safely be assumed to be missing at random.
184 participants (27.8%) had a final diagnosis of SNPT. 182 of
them had at least one positive culture for M.tuberculosis and 59 a
positive concentrated sputum smear. 2 of these 59 patients had
negative cultures.
184 participants (27.8%) had a final diagnosis of SNPT out of
whom 182 were diagnosed based on a positive culture for
M.tuberculosis Positive sputum concentrate was positive in 59
patients with two of them having negative cultures. In addition to
age, hemoptysis, weight loss and expectoration -variables included
in the score- fever and previous history of tuberculosis were
associated with SNPT in bivariate analysis (Table 1). On the other
hand, miliary infiltrate was not. In multivariate analysis, fever was
not a significant predictor but previous history of tuberculosis
(OR = 0.33; 95%CI 0.21–0.51) remained significant. The adjusted
Odds Ratios for the variables included in the evaluated score [17]
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were significantly different from 1, except for miliary infiltrate
(Table 2). Goodness of fit for the model was appropriate (p = 0.66;
Hosmer and Lemeshow test). Notwithstanding, in the subgroup of
patients without previous tuberculosis the only two patients with
miliary infiltrate had a final diagnosis of tuberculosis.
Table 3 shows the prevalence of SNPT in each of the strata
based on the score results and our previously suggested cut-off
points [17]. The score performed substantially better in patients
without history of previous tuberculosis (n = 424): in this group, the
prevalence of tuberculosis was 5.1% for low probability patients,
31.7% for intermediate probability patients and 72% for high
probability patients. For patients with previous history of
tuberculosis, the corresponding percentages were 8.3%, 18%
and 29.6% respectively. Figure 1 shows the prevalence of
tuberculosis for each value of the score in patients with and
without previous history of tuberculosis.
The area under the ROC curve (AUC ROC) was 0.76 (95% CI
0.72–0.80) for patients without and 0.56 (95% CI 0.50–0.62) for
patients with a previous diagnosis of tuberculosis (Figure 2). In
patients without previous tuberculosis, scores ,0 had a negative
likelihood ratio (LR) of 0.11 (95% CI 0.04–0.35) and a negative
predictive value of 94.9% (95% CI 85.9–98.9) and scores $5 had
a positive LR of 5.27(95% CI 2.94–9.45) and a positive predictive
value of 72.0% (95% CI 57.5–83.8). Of note, scores of $6 had a
positive LR of 10.9 (3.24–36.9) in patients without history of TB.
Discussion
Our study was designed to validate a scoring system developed
by Soto et al. [17] for estimating the probability of pulmonary
tuberculosis in smear negative suspects. Our main finding is that
the score performs well in patients without previous history of
PTB, but that it is rather useless in patients who had tuberculosis
in the past.
There exist several clinical prediction rules for clinical decision
making in tuberculosis and in SNPT in particular [13–16,22], but
Table 1. Sociodemographic, clinical and radiological variables in smear negative patients with and without pulmonary
tuberculosis. Lima, Peru, 2005–2008.
Total PTB No PTB OR P value
(n=663) (n =184) (n =479)
Male Sex 370(55.8) 109(59.2) 261(54.57) 1.21 (0.86–1.71) 0.27
Age (s.d) 41.4 (17.2) 36.3 (15.8) 43.3 (17.3) 0.97 (0.96–0.98) ,0.01
Fever 43(6.5%) 23(12.5) 20(4.2) 3.64 (1.51–8.80) ,0.01
Hemoptysis 205(30.9) 77(41.9) 128(26.7) 1.97 (1.38–2.82) ,0.01
Productive cough 443(66.8) 109(59.2) 334(69.7) 0.63 (0.44–0.90) ,0.01
Weight loss 417 (62.90) 132(71.7) 285(59.5) 1.73 (1.19–2.50) ,0.01
Previous history of TB 239(36.1) 45(24.5) 194(40.5) 0.48 (0.32–0.70) ,0.01
TB contact 314(47.36) 92(50) 222(46.4) 1.16 (0.82–1.63) 0.40
HIV infection{ 98(24.0) 24(19.5) 74(26.0) 0.69 (0.41–1.16) 0.16
Alcoholism 41 (6.18%) 11(6.0) 30(6.3) 0.95 (0.47–1.94) 0.89
Abnormal CXR 538(81.2) 167(90.8) 371(77.5) 2.86 (1.66–4.92) ,0.01
Miliary infiltrate 5(0.8) 3(1.6) 2(0.4) 3.95 (0.66–23.85) 0.13*
Apical infiltrate 379(57.2) 133(72.3) 246(51.4) 2.47 (1.71–3.57) ,0.01
Values in parenthesis are percentages unless otherwise indicated.
{Results available for 408 patients who accepted voluntary counselling and testing.
*Based on Fisher exact test.
PTB = Pulmonary tuberculosis.
doi:10.1371/journal.pone.0018486.t001
Table 2. Adjusted Odds Ratios for predictive variables included in the evaluated score [17] for smear negative pulmonary
tuberculosis. Lima, Peru, 2005–2008.
No Previous History of Tuberculosis Previous History of Tuberculosis
Variable OR 95% CI P value OR 95% CI P value
Hemoptysis 3.23 1.98–5.26 ,0.01 0.55 0.26–1.16 0.12
Age.45 0.42 0.25–0.72 ,0.01 0.44 0.21–0.91 0.03
Weight loss 1.77 1.07–2.93 0.03 1.74 0.84–3.59 0.13
Expectoration 0.61 0.38–1.00 0.05 0.89 0.39–2.03 0.79
Apical infiltrate 4.04 2.50–6.55 ,0.01 1.72 0.75–3.95 0.20
Miliary infiltrate NA* 2.04 0.17–23.91 0.57
*Not-entered in the model since the only two cases with miliary infiltrate and no previous history of TB had a final diagnosis of pulmonary tuberculosis.
doi:10.1371/journal.pone.0018486.t002
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their utility ought to be assessed in a different sample from the one
in which it was derived. To our knowledge, only 1 clinical
algorithm has been evaluated independently [22], apart from the
score assessed in this study. In addition, most prediction rules
derived in resource constrained countries were developed without
relying on an adequate reference standard and some even used
clinical criteria only[23,24].
Culture is still considered the reference for diagnosis of
tuberculosis [12], but conventional solid cultures lack sensitivity
[1,5,7].We have used, besides the conventional solid media, two
different liquid culture media to improve isolation of M. tuberculosis
and applied a composite reference standard (positivity in an
additional concentrated sputum smear and/or any of 3 types of
culture). We did not culture a second sputum sample since its
incremental diagnostic yield is poor [25]. One of the liquid culture
media was not available during 2 short periods, but this
information is ‘‘missing at random’’ and should not bias our
results. Although there is theoretically a possibility of false
negatives, we are confident that their number must be small and
should not invalidate the results of our study.
A limitation of our study is the setting, tertiary level hospitals.
This could affect the wider applicability of our findings, but it
reflects utilisation patterns and current clinical practice, certainly
in large parts of Latin America, where patients with clinical
suspicion of pulmonary tuberculosis and negative smears are
usually referred to higher level facilities to establish a diagnosis
with additional tests and/or make treatment decisions based on
expert opinion [26]. However, the presence of diseases such as
COPD amongst TB suspects may be higher at referral level. The
same holds for HIV co-infection rates. This could influence the
performance of the score and should be further evaluated before
application in primary care settings.
It is important to stress that the score should not replace clinical
judgement but is intended to be an aid to clinical decision making.
It is not a diagnostic test but permits to estimate the probability
that a suspect patient has smear negative pulmonary tuberculosis.
This approach of using 2 cut-off points and 3 categories is
considered appropriate when a single cut-off point does not
discriminate appropriately between the two disease states of
interest [27] and has also been used by other authors [28].The
high positive predictive value in patients with a score $5 justifies
TB treatment initiation, certainly if further confirmatory tests are
not readily available. For patients with a score ,0, the negative
predictive value permits to, at least a ‘‘wait and re-evaluate later’’
approach. We believe this would result in a reduction of diagnostic
delays for patients and in a more rational use of constrained
diagnostic resources for patients with intermediate to high
probabilities of TB. A formal economical evaluation should
confirm this, but was outside of the scope of the present study.
We found a higher proportion of subjects in the category with
intermediate probability of SNPT than in the original study [17].
Different performances of scores in the derivation and in a
validation population are normally expected and a reason why
clinical prediction rules must be assessed before being widely
applied [29]. Furthermore, a shift in an inclusion criterion (cough
.1 week were included in the derivation study against more than
two weeks in the present one) may have eliminated patients with
low probability of tuberculosis. On the other hand, SNPT suspects
Table 3. Prevalence of Smear Negative Pulmonary Tuberculosis (SNPT) according to score and history of previous tuberculosis,
Lima, Peru, 2005–2008.
Score,0 (low probability) Score 0–4 (intermediate probability) Score$5 (High probability)
No previous TB Previous TB No previous TB Previous TB No previous TB Previous TB
Number of suspect patients 59 12 315 200 50 27
Number with SNPT 3 1 100 36 36 8
% with SNPT 5.1 8.3 31.7 18.0 72.0 29.6
doi:10.1371/journal.pone.0018486.t003
Figure 1. Proportion of patients with smear negative pulmo-
nary tuberculosis by score values in subjects without and with
previous history of tuberculosis.
doi:10.1371/journal.pone.0018486.g001
Figure 2. Comparison of ROC curves for the score in patients
without (blue) and with (red) previous history tuberculosis.
doi:10.1371/journal.pone.0018486.g002
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with a likely diagnosis of PTB (in particular when a CXR revealed
a typical pattern) were probably not referred and hence not
included in our study. In practice, the score will be more useful in
less selected patient populations, when a substantial proportion of
suspects can be assigned to the high or low PTB probability
categories. Factors that drive patient selection will always also
determine this proportion, and the development of a rapid and
inexpensive complementary diagnostic test is, ultimately, the only
way forward.
All the variables in the score showed a strong statistical
association with SNPT in the bivariate and multivariable analysis,
except for miliary pattern in the CXR. This pattern was present in
only5 patients included and the two patients with a miliary pattern
and negative culture had a final diagnosis of tuberculous sequela.
These variables, besides others, have also been identified in
previous studies as predictors of SNPT [4,14,15,30,31]. Our
scoring system uses comparable predictive findings to Mello’s
logistic regression based score [15], the only other clinical
prediction rule for SNPT developed in a Latin-American setting,
that includes presence of typical X-ray signs, expectoration, weight
loss and age. Both scores are quite different from scores derived in
African populations [32,33] –where HIV co-infection are much
higher- and in developed countries[16,34–36] –where TB
incidence rates are much lower. The former include variables like
lymphadenopathy or low haematocrit in the former and the latter
immigrant status, BCG vaccination and contact history. These
signs and symptoms seem less useful in our setting, which
underscores the need for local adaptation and validation of
clinical prediction rules.
The evaluated clinical score [17] is a useful tool for assessing, in
Peru and possibly in Latin-America, the probability of pulmonary
tuberculosis in suspects without previous history of PTB. It can
support the decision of treatment initiation or deferral in patients
with high or low score based probabilities and indicates the need
for further work-up in the group with intermediate probabilities.
The adoption of locally validated clinical prediction rules can
reduce variability in assessment and management of smear
negative tuberculosis. It should become an important subject of
operational research in all resource constrained settings.
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